Blog - INTERNET MÉDICA

■ Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements

Q Li, X Li, J Kwong et al

BMJ Open 2016 (6)

http://bmjopen.bmj.com/content/7/6/e014928

http://bmjopen.bmj.com/content/bmjopen/7/6/e014928.full.pdf

■ Factors associated with initiation and persistent of urate-lowering therapy

Mats Dehlin, Emin Hoxha Ekström, Max Petzold et al

Arthritis Res Ther. 2017; 19: 6.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240247/

■ Guidelines for the treatment of gout: a Swiss perspective

H Wüthrich, F Alromaih, A So

Swiss Med Wkly 2016, vol 146: w14341

https://smw.ch/article/doi/smw.2016.14341/

■ Treatment of hyperuricemia in gout: current therapeuticas options, latest developments and clinical implication

Sebastian E. Sattui, Angelo L. Gaffo

Ther Adv Musculoskelet Dis. 2016 Aug; 8(4): 145–159

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959626/

■ The genetics of gout: towards personalized medicine?

Nicola Dalbeth, Lisa K. Stamp, Tony R. Merrima

BMC Med. 2017; 15: 108

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452604/

■ What makes gouty inflammation so variable?

Robert Terkeltaub

BMC Med. 2017; 15: 158

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561591/

■ Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data

Jasvinder A. Singh, John Cleveland

BMC Med. 2017; 15: 59

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361697/

■ Gout and subsequent erectile dysfunction: a population-based cohort study from England

Alyshah Abdul Sultan, Christian Mallen, Richard Hayward et al

Arthritis Res Ther. 2017; 19: 123

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461678/

■ Incidence of an risk factors for nephrolithiasis in patients with gout and the general population, a cohort study

J. Landgren, L. T. H. Jacobsson, U. Lindström et al

Arthritis Res Ther. 2017; 19: 173.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525359/

■ An optimal ultrasonography diagnostic test for early gout: a prospective study

E Norkuviene, M Petraitis, I Apanaviciene et AL

J Int Med Res 2017, vol 45 (4): 1417-1429

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625526/

■ Guidelines for the treatment of gout: a Swiss perspective

H Wüthrich, F Alromaih, A So

Swiss Med Wkly 2016, vol 146: w14341

■ Chronic tophaceous gout in patients with psoriasis

Lobato, Laís Cruz et al.

An. Bras. Dermatol., Feb 2017, vol.92, no.1, p.104-106

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000100104&lng=pt&nrm=iso

■ Use of febuxostat in the management of gout in the United Kingdom

Arabella Waller, Kelsey M. Jordan

Ther Adv Musculoskelet Dis. 2017 Feb; 9(2): 55–64

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315226/

■ Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options

Thomas Bardin, Pascal Richette

BMC Med. 2017; vol 15: 123

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494879/

■ Chronic tophaceous gout

M Jabalameli, A Bagherifard, H Hadi et al

QJM: An International Journal of Medicine 2017, vol 110 (4): 239-240

https://academic.oup.com/qjmed/article/110/4/239/2911047/Chronic-tophaceous-gout

■ Chronic tophaceous gout

R Angalla, A Mounir, S Driouich et al

QJM: An International Journal of Medicine 2017, vol 109 (10): 681-682

https://academic.oup.com/qjmed/article/109/10/681/2440068/Chronic-tophaceous-gout

■ Miliarial gout: a rare presentation of extensive cutaneous tophi

T –L Hung, W –M Wang, C –P Chiang

QJM: An International Journal of Medicine 2016, vol 109 (12)

https://academic.oup.com/qjmed/article/109/12/811/2631776/Miliarial-gout-a-rare-presentation-of-extensive

■ Effectiveness of an electronic patient-centred self-management tool for gout sufferers: a cluster randomized controlled trail protocol

R O Day, L J Fresham, A D Nguyen et AL

BMU Open 2017, vol 16 (10): e017281

http://bmjopen.bmj.com/content/7/10/e017281

■ Lumbar spinal stenosis attributable to tophaceous gout: case report and review of the literature

W Wang, Q Li, W Liu

Ther Clin Risk Manag 2017, vol 13: 1287-1293

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628693/

■ Gout and comorbity: a nominal group study of people with gout

Singh JA.

Arthritis Res Ther. 2017 Sep 15;19(1):204

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603046/

■ Incident gout and erectile dysfunction: Is hyperuricaemia the elephant in the room?

A Abhishek, M Doherty

Arthritis Res Ther 2017, vol 19: 184

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553804/

■ Factors associated with initiation and persistence of urate-lowering therapy

M Dehlin, E H Ekström, M Petzold et al

Arthritis Res Ther 2017, vol 19: 6

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240247/

■ Asymptomatic hyperuricemia and chronic kidney disease: narrative review of a treatment controversial

Theodoros Eleftheriadis, Spyridon Golphinopoulos, Georgios Pissas, Ioannis Stefanidis

J Adv Res. 2017 , vol 8(5): 555–56

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512148/

■ The role of hyperuricemia on vascular endothelium dysfunction

Haitao Zhen, Fen Gui

Biomed Rep. 2017 vol 7(4): 325–330

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590038/

■ Asymptomatic hyperuricemia is a strong risk factor for resistant hypertension in elderly subjects from general population

Alberto Mazza, Salvatore Lenti, Laura Schiavon, Alvise Del Monte et al

Biomed Pharmacother. 2017, vol 86: 590–594

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331939/

■ An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia

Marilisa Bove, Arrigo Francesco Giuseppe Cicero, Maddalena Veronesi, Claudio Borghi

Vasc Health Risk Manag. 2017; vol 13: 23–28

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308472/

■ Trea-to-target (T2T) recommendation for gout

U Kiltz, J Smolen, T Bardin, A C Solal et al

Annals of Rheumatic Diseases 2017, vol 76 (4)

http://ard.bmj.com/content/76/4/632

■ Artritis seudoséptica presenta sinovitis por cuerpo extraño en un paciente con gota

Valerio-Morales, IA et al.

Acta ortop. mex, Abr 2015, vol.29, no.2, p.123-126

http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2306-41022015000200011&lng=en&nrm=iso

■ Diagnosis, treatment, and prevention of gout

B L Hainer, E Matheson, T Wilkes

American Family Physicians 2014, vol 90 (12): 831-836

http://www.aafp.org/afp/2014/1215/p831.html

■ Hiperuricemia y gota: el papel de la dieta

Álvarez-Lario, Bonifacio and Alonso-Valdivielso, J. L.

Nutr. Hosp., Abr 2014, vol.29, no.4, p.760-77

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112014000400007&lng=en&nrm=iso

■ by Dr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

Rua Gonçalves Dias 202

Belo Horizonte/MG/Brasil

31 30033306 / 40204020

CRMMG: 7026

Email: pfleite1873@gmail.com

Febre reumática Online (Rheumatic fever)

Por Paulo Leite 20/10/2017

■ Febre reumática: atualização dos critérios de Jones à luz da revisão da American Heart Association – 2015

Pereira, Breno Álvares de Faria, Belo, Alinne Rodrigues and Silva, Nilzio Antônio da

Rev. Bras. Reumatol.,Aug 2017, vol.57, no.4, p.364-36

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042017000400364&lng=pt&nrm=iso&tlng=pt

■ Evolução Doppler Ecocardiográfica das Lesões Valvares Mitral e Aórtica em Crianças e Adolescentes com Cardite Reumática Subclínica e Leve

Carvalho, Lelia Maria de Almeida, Araújo, Fátima Derlene da Rocha and Meira, Zilda Maria Alve

Int. J. Cardiovasc. Sci., Sept 2017, vol.30, no.5, p.391-400

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472017000500391&lng=en&nrm=iso&tlng=pt

■ . Surgical Treatment of Atrial Fibrillation in Patients with Rheumatic Valve Disease.

Chavez, Ernesto Koehleret AL

Braz. J. Cardiovasc. Surg.,June 2017, vol.32, no.3, p.202-209

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382017000300202&lng=en&nrm=iso

■ Echocardiographic screening for rheumatic heart disease in indigenous Australina children: a cost-utility analysis

K Roberts, J Cannon, D Atkinson et al

J Am Heart Assoc 2017, vol 6 93): e004515

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524001/

■ Clinical impact and cost of echocardiographic screening for rheumatic heart disease

J N Kirkpatrick, C M Otto

Journal of the American Heart Association 2017: vol 6: e005666

http://jaha.ahajournals.org/content/6/3/e005666

■ Long-term outcomes from acute rheumatic fever and rheumatic heart disease – Clinical Perpective

V Y F He, J R Condon, A P Ralph et al

Circulation 2016, vol 134: 222-232

http://circ.ahajournals.org/content/134/3/222

■ Rheumatic fever with severe carditis: still prevalent in the South West Pacific

T K Nandra, N J Wilson, J Artrip, B Pagis

BMJ Case Reports 2017,

http://casereports.bmj.com/content/2017/bcr-2016-218954.full

■ Treatment of Chronic Atrial Fibrillation During Surgery for Rheumatic Mitral Valve Disease

Gonçalves, Flavio Donizete et AL

Braz. J. Cardiovasc. Surg., Sept 2016, vol.31, no.4, p.318-324

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382016000400318&lng=en&nrm=iso

■ Parameters indicative of persistence of valvular pathology at initial diagnosis in acute rheumatic carditis: the role of albumin and CD19 expression.

Oner, Talihaet al.

Pediatr. (Rio J.), Dec 2016, vol.92, no.6, p.581-58

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572016000700581&lng=en&nrm=iso

■ Cardiovascular comorbidity in inflammatory rheumatological conditions

Jürgen Braun, Klaus Krüger, Bernhard Manger et al

DtschArztebl Int. 2017 Mar; 114(12): 197–203

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397890/

■ Group A streptococcus, acute rheumatic fever and rheumatic heart disease: epidemiology and clinical considerations

L J Zühlke, A Beaton, M E Engel et al

Curr Treat Options Cardiovasc Med 2017, vol 19 (2): 15

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346434/

■ Rheumatic heart disease – an iceberg in tropical waters

E Marijon, D S Celermajer, X Jouven

N Engl J Med 2017, vol 377: 780-781

http://www.nejm.org/doi/pdf/10.1056/NEJMe1705840

■ Global, regional, and National Burden of rheumatic heart disease, 1990-2015

D A Watkins, C O Johnson, S M Colquhoun et al

N Engl J Med 2017, vol 377: 713-722

http://www.nejm.org/doi/full/10.1056/NEJMoa1603693

■ Rheumatic heart disease screening: current concepts and challenges

S Dougherty, M Khorsandi, P Herbst

Annals of Pediatric Cardiology 2017, vol 10 (1): 39-49

http://www.annalspc.com/article.asp?issn=0974-2069;year=2017;volume=10;issue=1;spage=39;epage=49;aulast=Dougherty

■ Update on diagnosis of acute rheumatic fever: 2015 Jones criteria

A G Eroglu

TurkPediatriArs 2016, vol 51 (1): 1-7

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829161/

■ Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation

E Okello, C T Kibgebecker, A Beaton et al

BMC CardiovascDisord 2017, vol 17: 20

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219796/

■ Screening for rheumatic heart disease: Is a paradigm shift required?

L D Hunter, M Monaghan, G Lloyd et al

Echo Res Pract sept 2017

http://www.echorespract.com/content/early/2017/09/01/ERP-17-0037.full.pdf+html

■ Rheumatic multiple valve disease and severe asymptomatic arterial occlusion

M Strachinaru, P Wauthy, C Goffin, N Damry

European Heart Journal, 2016, vol 37, issue 26

■ Associação entre febre reumática e arterite de Takayasu – Relato de caso

Gormezano, Natali W.S. et al

Rev. Bras. Reumatol.,Apr 2016, vol.56, no.2, p.178-180

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042016000200178&lng=en&nrm=iso&tlng=pt

■Dificuldades no diagnóstico diferencial entre arterite de Takayasu e febre reumática: relato de caso

Ferreira, Taciana Fernandes Araújo, Freire, Marlene and Teodoro, Reginaldo

Rev. Bras. Reumatol., Fev 2016, vol.56, no.1, p.90-92

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042016000100090&lng=en&nrm=iso

■ Mortality due to rheumatic heart disease

A Prasad, S Kumar, B K Singh

Br J Cardiol 2015, vol 22: 11

https://bjcardio.co.uk/2015/02/correspondence-mortality-due-to-rheumatic-heart-disease-in-india-stringent-preventive-measures-needed-in-developing-world/

■ Mitral valve replacement: follow-up of 444 patients operated on in the last decade

V Bihun, G G Coutinho, P E Antunes, M J Antunes

European Heart Journal, 2013, vol 34, issue suppl_1

https://academic.oup.com/eurheartj/article/doi/10.1093/eurheartj/eht310.4438/2862499/Mitral-valve-replacement-followup-of-444-patients

■ Echocardiographic screening for rheumatic heart disease issues for the Cardiology Community

A Saxena, L Zuhlkey, N Wilsonx et al

Global Heart 2013, vol 8 (3)

http://www.amjmed.com/article/S2211-8160(13)00110-5/pdf

■ Acute rheumatic fever and rheumatic heart disease – clinical perspective

J G Lawrence, J R Carapetis, K Griffiths et al

Circulation 2013, vol 128: 492-501

http://circ.ahajournals.org/content/128/5/492

■ Febre Reumática: revisão sistemética

A Peixoto, L Linhar

Rev Bras Clin Med 2011, vol 9 (3): 234-238

http://files.bvs.br/upload/S/1679-1010/2011/v9n3/a1983.pdf

■byDr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

CRMMG: 7026

Email: pfleite1873@gmail.com